Human Gene MIR376A2 (ENST00000636782.1) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
LF209655 - JP 2014500723-A/17158: Polycomb-Associated Non-Coding RNAs. MA445232 - JP 2018138019-A/17158: Polycomb-Associated Non-Coding RNAs. DM175431 - A nucleics Acid regulating cell growth. FV525931 - Nucleic acid controling mast cell degranulation. HV491981 - WO 2011087154-A/154: Method For Screening Induced Pluripotent Stem Cells. HW262185 - JP 2013516982-A/154: Method For Screening Induced Pluripotent Stem Cells. HW505231 - JP 2014502606-A/133: MELANOMA TREATMENTS. HW505244 - JP 2014502606-A/146: MELANOMA TREATMENTS. HZ408418 - JP 2015528002-A/1015: CHIRAL CONTROL. JC208092 - Sequence 154 from Patent EP2524033. LG051752 - KR 1020150036642-A/1018: CHIRAL CONTROL. AY785912 - Homo sapiens microRNA hsa-RG-2, complete sequence. CS548435 - Sequence 1465 from Patent EP1777301. DJ442731 - Pancreatic Islet microRNA and Methods for Inhibiting Same. DM174484 - A nucleics Acid regulating cell growth. FV524374 - Nucleic acid controling mast cell degranulation. FW312178 - DETECTING NUCLEIC ACIDS. FW364272 - Oligonucleotides for modulating target RNA activity. HI561055 - Sequence 270 from Patent EP2190992. HI561056 - Sequence 271 from Patent EP2190992. HI965124 - Sequence 409 from Patent WO2010139812. HI966189 - Sequence 509 from Patent WO2010139811. HI967055 - Sequence 509 from Patent WO2010139810. HV036097 - WO 2011027893-A/28: A method for predicting the efficacy of chronic hepatitis C treatment. HV492042 - WO 2011087154-A/215: Method For Screening Induced Pluripotent Stem Cells. HV492046 - WO 2011087154-A/219: Method For Screening Induced Pluripotent Stem Cells. HV594156 - JP 2010538653-A/270: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV594157 - JP 2010538653-A/271: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF. HV595181 - JP 2010539959-A/562: Micromirs. HV938906 - JP 2011519579-A/1734: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation. HW262246 - JP 2013516982-A/215: Method For Screening Induced Pluripotent Stem Cells. HW262250 - JP 2013516982-A/219: Method For Screening Induced Pluripotent Stem Cells. HW505419 - JP 2014502606-A/321: MELANOMA TREATMENTS. HW505420 - JP 2014502606-A/322: MELANOMA TREATMENTS. HW505432 - JP 2014502606-A/334: MELANOMA TREATMENTS. HW505433 - JP 2014502606-A/335: MELANOMA TREATMENTS. HW669812 - JP 2013537538-A/543: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. HZ074207 - JP 2013535982-A/298: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ082880 - JP 2015513906-A/237: Stem Cell Microparticles. HZ157738 - JP 2015130862-A/562: Micromirs. HZ186585 - JP 2015146814-A/334: Oligonucleotides for modulating target RNA activity. HZ436661 - JP 2015529450-A/237: Stem Cell Microparticles. HZ480372 - JP 2015535430-A/878: TERMINALLY MODIFIED RNA. HZ790303 - JP 2016504050-A/2048: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401162 - Sequence 409 from Patent WO2011080318. JA402140 - Sequence 409 from Patent WO2011080315. JA403147 - Sequence 409 from Patent WO2011080316. JA405778 - Sequence 409 from Patent EP2336353. JA427161 - Sequence 494 from Patent WO2011072177. JA429304 - Sequence 409 from Patent WO2011095623. JA792020 - Sequence 69 from Patent WO2012089753. JA792313 - Sequence 28 from Patent WO2012089630. JA821213 - Sequence 1734 from Patent EP2285961. JB024408 - Sequence 28 from Patent EP2505663. JB049929 - Sequence 16 from Patent WO2013020926. JB074784 - Sequence 44 from Patent WO2012168448. JB136718 - Sequence 28 from Patent EP2476758. JB175314 - Sequence 346 from Patent WO2012101219. JB620383 - Sequence 363 from Patent WO2013063544. JB624450 - Sequence 270 from Patent EP2610342. JB624451 - Sequence 271 from Patent EP2610342. JB733811 - Sequence 3214 from Patent WO2013082448. JB835805 - Sequence 95 from Patent WO2013057567. JB982237 - Sequence 15 from Patent WO2013190091. JC037791 - Sequence 319 from Patent EP2643479. JC171865 - Sequence 237 from Patent WO2013150303. JC208153 - Sequence 215 from Patent EP2524033. JC208157 - Sequence 219 from Patent EP2524033. JC244654 - Sequence 274 from Patent WO2012020308. JC244899 - Sequence 527 from Patent WO2012020308. JC270152 - Sequence 543 from Patent WO2012020307. JC334261 - Sequence 179 from Patent EP2487240. JC513035 - Sequence 3288 from Patent WO2014113089. JC572676 - Sequence 237 from Patent WO2014125276. JC582364 - Sequence 237 from Patent WO2014125277. JE867507 - Sequence 314 from Patent WO2015128671. JE954060 - Sequence 237 from Patent WO2015052526. JE955813 - Sequence 237 from Patent WO2015052527. LF137565 - JP 2016507550-A/237: Method of Producing Microparticles. LF160327 - JP 2016513950-A/393: Oligomers with improved off-target profile. LF162530 - JP 2016513095-A/237: Stem Cell Microparticles and miRNA. LF953282 - JP 2016534103-A/237: Stem Cell Microparticles and miRNA. LG005627 - KR 1020150004822-A/237: STEM CELL MICROPARTICLES. LG053323 - KR 1020150059168-A/237: STEM CELL MICROPARTICLES. LG240562 - KR 1020160035087-A/237: STEM CELL MICROPARTICLES AND MIRNA. LP637006 - Sequence 56 from Patent EP2848702. LP726815 - Sequence 509 from Patent EP2883966. LP819085 - Sequence 509 from Patent EP3296406. LP896698 - Sequence 1562 from Patent EP3253886. LP939027 - Sequence 509 from Patent EP3184651. LP951743 - Sequence 249 from Patent WO2017157650. LQ070623 - Sequence 947 from Patent EP2964234. LQ278735 - Sequence 274 from Patent WO2016066288. LQ441037 - Sequence 44 from Patent EP3029157. LV470647 - JP 2016534036-A/237: Stem Cell Microparticles and miRNA. LX154666 - JP 2017509333-A/314: Biomarkers for Endometriosis. LX270609 - JP 2016056210-A/543: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. LY405246 - KR 1020160117535-A/551: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY536152 - KR 1020170120124-A/6: BIOMARKER PANEL FOR THE DETECTION OF CANCER. LZ215662 - JP 2017518753-A/13: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS. LZ233942 - JP 2017184756-A/334: Oligonucleotides for modulating target RNA activity. MA260485 - JP 2017505623-A/551: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA363525 - JP 2018509934-A/6: BIOMARKER PANEL FOR THE DETECTION OF CANCER. MA419957 - JP 2018518169-A/8: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420039 - JP 2018518169-A/90: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420064 - JP 2018518169-A/115: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420094 - JP 2018518169-A/145: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA420108 - JP 2018518169-A/159: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS. MA644124 - JP 2017113010-A/2048: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA730756 - JP 2017125065-A/543: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. MA732008 - JP 2017140048-A/878: TERMINALLY MODIFIED RNA. MP075724 - Sequence 63 from Patent WO2019002265. MS833565 - Sequence 270 from Patent EP3112464. MS833566 - Sequence 271 from Patent EP3112464. MS834263 - Sequence 409 from Patent EP3112479. MA801177 - JP 2018183181-A/2048: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129337 - Sequence 237 from Patent EP3470073. MP162260 - Sequence 237 from Patent WO2019069093. MP280711 - Sequence 131 from Patent WO2019111197. MP283624 - Sequence 131 from Patent WO2019111198.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: NR_030266, uc021scz.1, uc021scz.2, uc021scz.3 UCSC ID: ENST00000636782.1 RefSeq Accession: NR_030266
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|